Dyadic Applied BioSolutions (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company ...

The global growth factors market is growing steadily, expected to be valued at approximately US$2.5 billion in 2026 and ...

The global biosimilar contract manufacturing market size was valued at USD 9.22 billion in 2025 and is predicted to hit ...

Dyadic Applied BioSolutions ("Dyadic", "we", "us", "our", or the "Company") (NASDAQ: DYAI), a global biotechnology company producing precision-engineered ...

The global growth factors market is growing steadily, expected to be valued at approximately US$2.5 billion in 2026 and projected to reach US$3.7 billion ...

Scinai Immunotherapeutics Ltd. has acquired Recipharm Israel Ltd., operator of Recipharm’s manufacturing site in Yavne.

In the United States, aflibercept-yszy received Food and Drug Administration (FDA) approval in May 2024 as a biosimilar to ...

"This is the moment where planning becomes production," said Kim Thompson, Kraig Labs CEO and Founder. "Our 2026 roadmap was built around disciplined expansion, operational efficiency, and multi-ton ...

The market plays a crucial role in supporting modern industries by reducing development timelines and increasing success rates in protein expression projects. The Computer Assisted Protein Expression ...

ImmunityBio, Inc. , a commercial stage immunotherapy company developing next generation therapies that drive immunological memory and restore immune competence, today announced that the Company held ...

The Saudi Food and Drug Authority encouraged the company to submit a regulatory filing for its recombinant Bacillus ...

Testing thrombin generation in a woman with acquired hemophilia A, lupus, and heart disease showed that her clotting balance fluctuated with treatment.